February 9, 2018

 

Via Email and EDGAR

 

Chris Edwards
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549

 

Re:                             Jaguar Health, Inc.
Registration Statement on Form S-3

Filed January 31, 2018
File No. 333-222805

 

Ladies and Gentlemen:

 

Jaguar Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) be declared effective by the Securities and Exchange Commission on February 12, 2018, at 4:00 p.m., Eastern Standard Time, or as soon thereafter as is practicable.

 

Please confirm effectiveness by advising our counsel, Michael S. Lee of Reed Smith LLP, at (212) 549-0358.

 

Very truly yours,

 

 

 

Jaguar Health, Inc.

 

 

 

/s/ Lisa A. Conte

 

Lisa A. Conte

 

Chief Executive Officer and President

 

 

Jaguar Health, Inc. · 201 Mission Street, Suite 2375 · San Francisco, CA 94105

Tel: +1 (415) 371-8300 · Fax: +1 (415) 371-8311 · https://jaguar.health